Yiyuan Wang

Guangzhou, 510405, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Natural products in rheumatoid arthritis: Cell type-specific mechanisms and therapeutic implications.

Natural products in rheumatoid arthritis: Cell type-specific mechanisms and therapeutic implications.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: April 21, 2025

Oroxylin A suppresses breast cancer-induced osteoclastogenesis and osteolysis as a natural RON inhibitor.

Oroxylin A suppresses breast cancer-induced osteoclastogenesis and osteolysis as a natural RON inhibitor.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: January 09, 2024

Immune-Cell-Based Therapy for COVID-19: Current Status.

Immune-Cell-Based Therapy for COVID-19: Current Status.

Journal: Viruses

Published: August 19, 2023

Flot2 deficiency facilitates B cell-mediated inflammatory responses and endotoxic shock.

Flot2 deficiency facilitates B cell-mediated inflammatory responses and endotoxic shock.

Journal: Immunology

Published: March 21, 2023

Polyphyllin VII protects from breast cancer-induced osteolysis by suppressing osteoclastogenesis via c-Fos/NFATc1 signaling.

Polyphyllin VII protects from breast cancer-induced osteolysis by suppressing osteoclastogenesis via c-Fos/NFATc1 signaling.

Journal: International immunopharmacology

Published: February 22, 2023

IKKβ increases neuropilin-2 and promotes the inhibitory function of CD9+ Bregs to control allergic diseases.

IKKβ increases neuropilin-2 and promotes the inhibitory function of CD9+ Bregs to control allergic diseases.

Journal: Pharmacological research

Published: July 21, 2022

A Nitrobenzoyl Sesquiterpenoid Insulicolide A Prevents Osteoclast Formation via Suppressing c-Fos-NFATc1 Signaling Pathway.

A Nitrobenzoyl Sesquiterpenoid Insulicolide A Prevents Osteoclast Formation via Suppressing c-Fos-NFATc1 Signaling Pathway.

Journal: Frontiers in pharmacology

Published: August 04, 2021

Dendrobine attenuates osteoclast differentiation through modulating ROS/NFATc1/ MMP9 pathway and prevents inflammatory bone destruction.

Dendrobine attenuates osteoclast differentiation through modulating ROS/NFATc1/ MMP9 pathway and prevents inflammatory bone destruction.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: July 27, 2021

IL-10-producing regulatory B cells exhibit functional defects and play a protective role in severe endotoxic shock.

IL-10-producing regulatory B cells exhibit functional defects and play a protective role in severe endotoxic shock.

Journal: Pharmacological research

Published: June 03, 2019

Sinomenine inhibits osteolysis in breast cancer by reducing IL-8/CXCR1 and c-Fos/NFATc1 signaling.

Sinomenine inhibits osteolysis in breast cancer by reducing IL-8/CXCR1 and c-Fos/NFATc1 signaling.

Journal: Pharmacological research

Published: October 26, 2018

A marine fungus-derived nitrobenzoyl sesquiterpenoid suppresses receptor activator of NF-κB ligand-induced osteoclastogenesis and inflammatory bone destruction.

A marine fungus-derived nitrobenzoyl sesquiterpenoid suppresses receptor activator of NF-κB ligand-induced osteoclastogenesis and inflammatory bone destruction.

Journal: British journal of pharmacology

Published: October 25, 2018

B-cell-specific-peroxisome proliferator-activated receptor γ deficiency augments contact hypersensitivity with impaired regulatory B cells.

B-cell-specific-peroxisome proliferator-activated receptor γ deficiency augments contact hypersensitivity with impaired regulatory B cells.

Journal: Immunology

Published: June 19, 2018

Showing 1-12 of 14

Last Updated: 09/26/2026